These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3145680

  • 1. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF, Kinoshita JH, Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract] [Full Text] [Related]

  • 2. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
    Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
    [No Abstract] [Full Text] [Related]

  • 3. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
    Terubayashi H, Akagi Y.
    Jpn J Ophthalmol; 1989 Mar; 33(3):343-7. PubMed ID: 2507812
    [Abstract] [Full Text] [Related]

  • 4. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract] [Full Text] [Related]

  • 5. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF.
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [Abstract] [Full Text] [Related]

  • 6. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S, Simmons DA, Kern EF.
    Trans Assoc Am Physicians; 1986 Feb; 99():67-72. PubMed ID: 3111062
    [No Abstract] [Full Text] [Related]

  • 7. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Jpn J Ophthalmol; 1987 Jan; 31(2):305-14. PubMed ID: 3118085
    [Abstract] [Full Text] [Related]

  • 11. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y, Takahashi Y, Tanabe T, Ikebe H, Majima K, Miyatani H, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR.
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [Abstract] [Full Text] [Related]

  • 13. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N, Coco M, Aynedjian HS.
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [Abstract] [Full Text] [Related]

  • 14. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M, Sasaki K.
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract] [Full Text] [Related]

  • 15. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P.
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y, Terubayashi H, Ikebe H, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Feb; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 19. Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?
    Frank RN.
    Arch Ophthalmol; 1990 Sep; 108(9):1229-31. PubMed ID: 2119167
    [No Abstract] [Full Text] [Related]

  • 20. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.